SAMSUNG PHARM. Co., LTD. acquired 0.16% stake in GemVax Technology Co., Ltd. from Samsung Medicos Co., Ltd. for approximately KRW 220 million.
November 05, 2017
Share
SAMSUNG PHARM. Co., LTD. (KOSE:A001360) acquired 0.16% stake in GemVax Technology Co., Ltd. (KOSDAQ:A041590) from Samsung Medicos Co., Ltd. for approximately KRW 220 million on October 30, 2017. SAMSUNG PHARM. Co., LTD acquired 54,357 shares at KRW 4101 per share.
SAMSUNG PHARM. Co., LTD. (KOSE:A001360) completed the acquisition of 0.16% stake in GemVax Technology Co., Ltd. (KOSDAQ:A041590) from Samsung Medicos Co., Ltd. on October 30, 2017.
Flask Co Ltd, formerly Gemvaxzio Co Ltd, is a Korea-based company engaged in the interior business. The Company operates its business through three segments. The Interior Business segment is involved in the businesses of interior design and construction, such as furniture design, manufacture and installation, as well as architectural design and construction. The Energy Business segment mainly engages in the construction of renewable energy devices and facilities, such as ice thermal storage cooling systems and electricity storage systems (ESSs). The Leasing Business segment mainly engages in the leasing of shops.
FLASK CO., LTD. 
